Global mRNA Cancer Vaccines and Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

October 2018 | 119 pages | ID: G78AF8FED02GEN
GlobalInfoResearch

Abstracts

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

SCOPE OF THE REPORT:

The worldwide market for mRNA Cancer Vaccines and Therapeutics is expected to grow at a CAGR of roughly 20.5% over the next five years, will reach 210 million US$ in 2023, from 68 million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the mRNA Cancer Vaccines and Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Moderna Therapeutics
• CureVac
• Translate Bio
• BioNTech
• Sangamo Therapeutics
• Argos Therapeutics
• In-Cell-Art
• eTheRNA
• Ethris
• Tiba Biotechnology

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Adeno Carcinomas
• Mucinous Carcinomas
• Adenosquamous Carcinomas

Market Segment by Applications, can be divided into

• Infectious Disease
• Cancer
• Other

There are 15 Chapters to deeply display the global mRNA Cancer Vaccines and Therapeutics market.

Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of mRNA Cancer Vaccines and Therapeutics, with sales, revenue, and price of mRNA Cancer Vaccines and Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of mRNA Cancer Vaccines and Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, mRNA Cancer Vaccines and Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe mRNA Cancer Vaccines and Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 mRNA Cancer Vaccines and Therapeutics Introduction
1.2 Market Analysis by Type
  1.2.1 Adeno Carcinomas
  1.2.2 Mucinous Carcinomas
  1.2.3 Adenosquamous Carcinomas
1.3 Market Analysis by Applications
  1.3.1 Infectious Disease
  1.3.2 Cancer
  1.3.3 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Moderna Therapeutics
  2.1.1 Business Overview
  2.1.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 CureVac
  2.2.1 Business Overview
  2.2.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Translate Bio
  2.3.1 Business Overview
  2.3.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BioNTech
  2.4.1 Business Overview
  2.4.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sangamo Therapeutics
  2.5.1 Business Overview
  2.5.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Argos Therapeutics
  2.6.1 Business Overview
  2.6.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 In-Cell-Art
  2.7.1 Business Overview
  2.7.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 eTheRNA
  2.8.1 Business Overview
  2.8.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ethris
  2.9.1 Business Overview
  2.9.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Tiba Biotechnology
  2.10.1 Business Overview
  2.10.2 mRNA Cancer Vaccines and Therapeutics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 mRNA Cancer Vaccines and Therapeutics Manufacturer Market Share in 2017
  3.3.2 Top 6 mRNA Cancer Vaccines and Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET ANALYSIS BY REGIONS

4.1 Global mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Regions
  4.1.1 Global mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Regions (2013-2018)
  4.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)

5 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS BY COUNTRIES

5.1 North America mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Countries
  5.1.1 North America mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Countries (2013-2018)
  5.1.2 North America mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)

6 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS BY COUNTRIES

6.1 Europe mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Countries
  6.1.1 Europe mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
6.4 France mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS BY COUNTRIES

7.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
7.5 India mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS BY COUNTRIES

8.1 South America mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Countries
  8.1.1 South America mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Countries (2013-2018)
  8.1.2 South America mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA MRNA CANCER VACCINES AND THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)

10 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global mRNA Cancer Vaccines and Therapeutics Sales and Market Share by Type (2013-2018)
  10.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Adeno Carcinomas Sales Growth and Price
  10.2.1 Global Adeno Carcinomas Sales Growth (2013-2018)
  10.2.2 Global Adeno Carcinomas Price (2013-2018)
10.3 Mucinous Carcinomas Sales Growth and Price
  10.3.1 Global Mucinous Carcinomas Sales Growth (2013-2018)
  10.3.2 Global Mucinous Carcinomas Price (2013-2018)
10.4 Adenosquamous Carcinomas Sales Growth and Price
  10.4.1 Global Adenosquamous Carcinomas Sales Growth (2013-2018)
  10.4.2 Global Adenosquamous Carcinomas Price (2013-2018)

11 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Application (2013-2018)
11.2 Infectious Disease Sales Growth (2013-2018)
11.3 Cancer Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)

12 MRNA CANCER VACCINES AND THERAPEUTICS MARKET FORECAST (2018-2023)

12.1 Global mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 mRNA Cancer Vaccines and Therapeutics Market Forecast by Regions (2018-2023)
  12.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
  12.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
  12.2.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
  12.2.4 South America mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
  12.2.5 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
12.3 mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2018-2023)
  12.3.1 Global mRNA Cancer Vaccines and Therapeutics Sales Forecast by Type (2018-2023)
  12.3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2018-2023)
12.4 mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2018-2023)
  12.4.1 Global mRNA Cancer Vaccines and Therapeutics Sales Forecast by Application (2018-2023)
  12.4.2 Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure mRNA Cancer Vaccines and Therapeutics Picture
Table Product Specifications of mRNA Cancer Vaccines and Therapeutics
Figure Global Sales Market Share of mRNA Cancer Vaccines and Therapeutics by Types in 2017
Table mRNA Cancer Vaccines and Therapeutics Types for Major Manufacturers
Figure Adeno Carcinomas Picture
Figure Mucinous Carcinomas Picture
Figure Adenosquamous Carcinomas Picture
Figure mRNA Cancer Vaccines and Therapeutics Sales Market Share by Applications in 2017
Figure Infectious Disease Picture
Figure Cancer Picture
Figure Other Picture
Figure United States mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria mRNA Cancer Vaccines and Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Type and Applications
Table Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CureVac Basic Information, Manufacturing Base and Competitors
Table CureVac mRNA Cancer Vaccines and Therapeutics Type and Applications
Table CureVac mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Translate Bio Basic Information, Manufacturing Base and Competitors
Table Translate Bio mRNA Cancer Vaccines and Therapeutics Type and Applications
Table Translate Bio mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BioNTech Basic Information, Manufacturing Base and Competitors
Table BioNTech mRNA Cancer Vaccines and Therapeutics Type and Applications
Table BioNTech mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Type and Applications
Table Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Type and Applications
Table Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table In-Cell-Art mRNA Cancer Vaccines and Therapeutics Type and Applications
Table In-Cell-Art mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table eTheRNA Basic Information, Manufacturing Base and Competitors
Table eTheRNA mRNA Cancer Vaccines and Therapeutics Type and Applications
Table eTheRNA mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ethris Basic Information, Manufacturing Base and Competitors
Table Ethris mRNA Cancer Vaccines and Therapeutics Type and Applications
Table Ethris mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Type and Applications
Table Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global mRNA Cancer Vaccines and Therapeutics Sales by Manufacturer (2016-2017)
Figure Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Manufacturer in 2017
Table Global mRNA Cancer Vaccines and Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 mRNA Cancer Vaccines and Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 mRNA Cancer Vaccines and Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Sales by Regions (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Regions (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue by Regions (2013-2018)
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Regions in 2013
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Regions in 2017
Figure North America mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure South America mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure North America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2013-2018)
Table North America mRNA Cancer Vaccines and Therapeutics Sales by Countries (2013-2018)
Table North America mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries in 2013
Figure North America mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries in 2017
Table North America mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2013-2018)
Table North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2013
Figure North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2017
Figure United States mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe mRNA Cancer Vaccines and Therapeutics Sales by Countries (2013-2018)
Table Europe mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2013-2018)
Figure Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2016
Figure Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2017
Figure Germany mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure UK mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure France mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries 2017
Figure China mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure India mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure South America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2013-2018)
Table South America mRNA Cancer Vaccines and Therapeutics Sales by Countries (2013-2018)
Table South America mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries in 2017
Table South America mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2013-2018)
Table South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa mRNA Cancer Vaccines and Therapeutics Sales and Growth Rate (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Sales by Type (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Sales Share by Type (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue by Type (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Type (2013-2018)
Figure Global Adeno Carcinomas Sales Growth (2013-2018)
Figure Global Adeno Carcinomas Price (2013-2018)
Figure Global Mucinous Carcinomas Sales Growth (2013-2018)
Figure Global Mucinous Carcinomas Price (2013-2018)
Figure Global Adenosquamous Carcinomas Sales Growth (2013-2018)
Figure Global Adenosquamous Carcinomas Price (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Sales by Application (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Sales Share by Application (2013-2018)
Figure Global Cancer Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global mRNA Cancer Vaccines and Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global mRNA Cancer Vaccines and Therapeutics Sales Forecast by Regions (2018-2023)
Table Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
Figure Europe Sales mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
Figure South America Sales mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales mRNA Cancer Vaccines and Therapeutics Market Forecast (2018-2023)
Table Global mRNA Cancer Vaccines and Therapeutics Sales Forecast by Type (2018-2023)
Table Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2018-2023)
Table Global mRNA Cancer Vaccines and Therapeutics Sales Forecast by Application (2018-2023)
Table Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List